Aenova is a contract manufacturer of dietary supplements, including softgels, hard capsules, tablets, granules and pellets, and effervescents.
BC Partners (London), a private equity firm, has acquired the dietary supplement contract manufacturer Aenova Group (Pähl, Germany) from its previous majority stakeholder, Bridgepoint.
Aenova is a leading contract manufacturer of dietary supplements, including softgels, hard capsules, tablets, granules and pellets, and effervescents.
“As Europe’s leading service provider in the development, manufacture, and marketing of pharmaceuticals and dietary supplements for a broad range of customers in the pharmaceuticals and healthcare sector, Aenova is superbly positioned,” says BC Partners managing partner Stefan Zuschke. “In addition to continued organic growth, we are also planning further acquisitions to broaden the company’s range and to additionally enhance its competitive position in the international markets.”
The transaction is still subject to antitrust clearance.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.